The 41BB-agonist potentiates the therapeutic efficacy of a combined irreversible electroporation ablation treatment of lung cancer by promoting unexpected CD8(+)CD103(+) cDC1 and tissue-resident memory T cell responses
41BB激动剂通过促进意想不到的CD8(+)CD103(+) cDC1和组织驻留记忆T细胞反应,增强了肺癌联合不可逆电穿孔消融治疗的疗效。
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1688281
Fang, Chen; Wu, Zhaojia; Leary, Scot C; Bai, Yiling; Yu, Michelle; Baniak, Nicolas; Ahmed, Shahid; Groot, Gary; Moser, Michael; Zhang, Wenjun; Zhang, Bing; Huang, Junqiong; Ma, Haitao; Feng, Yu; Xiang, Jim
肺癌
肿瘤
T细胞
肿瘤免疫
CD103
CD8
CD10
T细胞
细胞生物学
免疫/内分泌